Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Chaves Conde, M"'
Autor:
Ayala-de Miguel C; Servicio Oncología Médica, Hospital Universitario Virgen de Valme, Ctra, de Cádiz Km 548,9, Seville C.P. 41014, Spain. Electronic address: cadm3004@gmail.com., Jiménez-Castro J; Servicio Oncología Médica, Hospital Universitario Virgen de Valme, Ctra, de Cádiz Km 548,9, Seville C.P. 41014, Spain. Electronic address: jeronimo.jimenez.castro.sspa@juntadeandalucia.es., Sánchez-Vegas A; Servicio Oncología Médica, Hospital Universitario Virgen de Valme, Ctra, de Cádiz Km 548,9, Seville C.P. 41014, Spain. Electronic address: adrianvegas89@gmail.com., Díaz-López S; Servicio Oncología Médica, Hospital Universitario Virgen de Valme, Ctra, de Cádiz Km 548,9, Seville C.P. 41014, Spain. Electronic address: sebastian.diaz.sspa@juntadeandalucia.es., Chaves-Conde M; Servicio Oncología Médica, Hospital Universitario Virgen de Valme, Ctra, de Cádiz Km 548,9, Seville C.P. 41014, Spain. Electronic address: manuel.chaves.sspa@juntadeandalucia.es.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Oct; Vol. 202, pp. 104454. Date of Electronic Publication: 2024 Jul 21.
Autor:
Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-Ro, Seoul, 03722, Republic of Korea. cbc1971@yuhs.ac.; Severance Hospital and Yonsei University, 50-1 Yonsei-Ro, Seoul, Korea. cbc1971@yuhs.ac., Braña I; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain., Cirauqui B; Oncology Department, Catalan Institut of Oncology (ICO) Badalona, Crta Canyet sn, Barcelona, 08916, Spain., Aksoy S; Hacettepe University Cancer Institute, Hacettepe Mh., Ankara, 06100, Turkey., Couture F; CHU de Québec - Hôtel-Dieu de Québec, 11 Cote du Palais, Quebec City, QC, G1R 2J6, Canada., Hong RL; National Taiwan University Hospital, No.1, Changde St., Zhongzheng District, Taipei, 100, Taiwan., Miller WH Jr; Jewish General Hospital and McGill University, 3755 Cote St., Montreal, H3S 1Z1, Canada., Chaves-Conde M; Hospital de Nuestra Senora de Valme, Ctra Cadiz sn, Seville, 41014, Spain., Teixeira M; Instituto Português de Oncologia de Coimbra Francisco Gentil EPE, Avenida Bissaya Barreto 98, Coimbra, 3000-075, Portugal., Leopold L; Incyte Corporation, Wilmington, DE, 19803, USA., Munteanu M; Incyte Corporation, Wilmington, DE, 19803, USA., Ge JY; Merck & Co., Inc., P.O. Box 2000, 126 East Lincoln Ave., Rahway, NJ, 07065, USA., Swaby RF; Merck & Co., Inc., P.O. Box 2000, 126 East Lincoln Ave., Rahway, NJ, 07065, USA., Hughes BGM; Royal Brisbane and Women's Hospital and University of Queensland, Butterfield Street, Ground Floor, Building 34, Brisbane, QLD, 4029, Australia.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Jul 25; Vol. 23 (Suppl 1), pp. 1254. Date of Electronic Publication: 2024 Jul 25.
Autor:
Ayala-de Miguel C; Servicio Oncología Médica, Hospital Universitario Valme, Ctra. de Cádiz Km 548,9, C.P.: 41014, Seville, Spain., Jiménez-Castro J; Servicio Oncología Médica, Hospital Universitario Valme, Ctra. de Cádiz Km 548,9, C.P.: 41014, Seville, Spain. jerojc@gmail.com., Sánchez-Vegas A; Servicio Oncología Médica, Hospital Universitario Valme, Ctra. de Cádiz Km 548,9, C.P.: 41014, Seville, Spain., Díaz-López S; Servicio Oncología Médica, Hospital Universitario Valme, Ctra. de Cádiz Km 548,9, C.P.: 41014, Seville, Spain., Chaves-Conde M; Servicio Oncología Médica, Hospital Universitario Valme, Ctra. de Cádiz Km 548,9, C.P.: 41014, Seville, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jun; Vol. 26 (6), pp. 1287-1299. Date of Electronic Publication: 2023 Dec 09.
Autor:
Díaz-López S; Medical Oncology Department, Hospital Universitario Valme, Seville 41014, Andalucía, Spain., Jiménez-Castro J; Medical Oncology Department, Hospital Universitario Valme, Seville 41014, Andalucía, Spain. jerojc@gmail.com., Robles-Barraza CE; Medical Oncology Department, Hospital Universitario Valme, Seville 41014, Andalucía, Spain., Ayala-de Miguel C; Medical Oncology Department, Hospital Universitario Valme, Seville 41014, Andalucía, Spain., Chaves-Conde M; Medical Oncology Department, Hospital Universitario Valme, Seville 41014, Andalucía, Spain.
Publikováno v:
World journal of gastrointestinal oncology [World J Gastrointest Oncol] 2024 Apr 15; Vol. 16 (4), pp. 1166-1179.
Autor:
Rubió-Casadevall J; Medical Oncology Department, Institut Català d'Oncologia Girona, Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Cirauqui Cirauqui B; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain., Martinez Trufero J; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Plana Serrahima M; Medical Oncology Department, Institut Català d'Oncologia (ICO-Hospitalet), IDIBELL, Hospitalet de Llobregat, Llobregat, Spain., García Castaño A; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Carral Maseda A; Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain., Iglesias Docampo L; Medical Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Pérez Segura P; Medical Oncology Department, Hospital Clínico San Carlos, IdISSC, Madrid, Spain., Ceballos Lenza I; Medical Oncology Department, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain., Gutiérrez Calderón V; UGCI Oncol. Hospital Universitario Regional y Virgen Victoria, IBIMA, Málaga, Spain., Fuster Salvà J; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Pena Álvarez C; Medical Oncology Department, Centro Oncológico Galicia, A Coruña, Spain., Hernandez I; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Del Barco Morillo E; Medical Oncology Department, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain., Chaves Conde M; Medical Oncology Department, Hospital Universitario Virgen de Valme, Sevilla, Spain., Martínez Galán J; Medical Oncology Department, Hospital Universitario Virgen Nieves, Instituto de Investigación Biosanitaria ibs, Granada, Spain., Durán Sánchez M; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain., Quiroga V; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain., Ortega E; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain., Mesia R; Medical Oncology Department, Institut Català d'Oncologia Badalona, B-ARGO Group, IGTP, Badalona, Spain.; Spanish Group of Head and Neck Cancer Treatment (TTCC), Madrid, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Aug 01; Vol. 13, pp. 1226939. Date of Electronic Publication: 2023 Aug 01 (Print Publication: 2023).
Publikováno v:
In Programa de Formación Médica Continuada acreditado 2010 10(68):4637-4645
Importance: Locoregionally advanced head and neck squamous cell cancer (HNSCC) is treated curatively; however, risk of recurrence remains high among some patients. The ERBB family blocker afatinib has shown efficacy in recurrent or metastatic HNSCC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::09e4cd3c77f495e9c9d9e7a7c2953be4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077845
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077845
Autor:
Cirauqui Cirauqui, B., Martinez Trufero, J., Plana Serrahima, M., García Castaño, A., Rubió-Casadevall, J., Carral Maseda, A., Iglesias Docampo, L., Pérez Segura, P., Ceballos Lenza, I., Gutierrez Calderon, V., Fuster Salva, J., Pena Álvarez, C., Arrazubi Arrula, V., del Barco Morillo, E., Chaves Conde, M., Martínez Galán, J., Durán Sánchez, M., Quiroga, V., Ortega, E., Mesia Nin, R.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S852-S853
Autor:
Miguel Luken, MJ de, Chaves Conde, M, Quintana, Begoña, Menoyo, Alicia, Tirado, Isabel, Miguel Luken, Veronica de, Pachón Díaz, Jerónimo, Carnero Moya, Amancio
Publikováno v:
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
Current larynx preservation treatments have achieved an improvement of laryngoesophageal dysfunction-free survival (LDS) but lead to significant toxicities and recurrences. At present, there is no evidence to select the group of patients that may ben
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6be3504b3c38f6df6aae4d4ba1b0259b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.